Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Am Coll Clin Pharm. 2021 Sep 30;4(11):1410–1419. doi: 10.1002/jac5.1525

Table 3:

Characteristics of CMM delivery of patients who received CMM pre- and post-PCT

Pre-PCT
(N= 554)
Post-PCT
(N= 880)
p-value
Number of CMM visits n (%) 0.1668
 1 245 (44.2%) 342 (38.9%)
 2 120 (21.7%) 224 (25.5%)
 3 71 (12.8%) 127 (14.4%)
 4+ 118 (21.3%) 187 (21.3%)
Mean number of MTPs identified (SD) 2.2 (1.73) 2.7 (1.75) <0.001
MTP Classification n (%)
Indication
Unnecessary Drug Therapy 76 (13.7%) 216 (24.5%) <0.001
Needs additional therapy 329 (59.4%) 605 (68.8%) 0.0003
Effectiveness
Different Drug Needed 124 (22.4%) 215 (24.4%) 0.3739
Dose too low 251 (45.3%) 451 (51.3%) 0.0284
Safety
Adverse drug reaction 161 (29.1%) 320 (36.4%) 0.0043
Dose too high 140 (25.3%) 268 (30.5%) 0.0341
Adherence 167 (30.1%) 346 (39.3%) 0.0004

CMM comprehensive medication management, PCT primary care transformation, MTP medication therapy problem